LP
LGL Partners Portfolio holdings
AUM
$225M
1-Year Return
14.87%
This Quarter Return
+10.25%
1 Year Return
+14.87%
3 Year Return
+56.73%
5 Year Return
+86.98%
10 Year Return
–
AUM
$730M
AUM Growth
+$160M
(+28%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
14.1%
Top 10 Holdings %
Top 10 Hldgs %
75.68%
Holding
102
New
8
Increased
55
Reduced
17
Closed
2
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$56.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$44.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$24.6M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$10.4M |
| 5 |
iShares National Muni Bond ETF
MUB
|
$1.53M |
Top Sells
| 1 |
iShares MSCI Intl Value Factor ETF
IVLU
|
$42.1M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
$158K |
| 3 |
Johnson & Johnson
JNJ
|
$157K |
| 4 |
O'Reilly Automotive
ORLY
|
$144K |
| 5 |
Procter & Gamble
PG
|
$117K |
Sector Composition
| 1 | Financials | 1.25% |
| 2 | Technology | 0.99% |
| 3 | Consumer Discretionary | 0.75% |
| 4 | Communication Services | 0.69% |
| 5 | Healthcare | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Tesla
TSLA
$1.09T
| – | – |
-329
| Closed | -$82.3K |
|
102
SAB Biotherapeutics
SABS
$21M
| – | – |
-2,300
| Closed | -$14.5K |
|